Concepedia

Author

D Milligan

Heartlands Hospital

Also Known As

D Milligan, D W Milligan, D. Milligan, D. W Milligan, D. W. Milligan, D.W MILLIGAN, D.W. Milligan, D.W. Milligan MD, D. W. Milligan, Dawn Milligan

78

Publications

4.3K

Citations

31

H-Index

73

Concepts

All Affiliations

Heartlands HospitalLeeds General InfirmaryUniversity College LondonUniversity of BirminghamNottingham City Hospital
DM

About

D Milligan is an author at Heartlands Hospital specializing in medicine, hematology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

30

2.8K

2

Blood Transplantation

8

8

730

3

Health Sciences

5

5

1.2K

4

Education

1

1

15

5

Social Sciences

1

1

103

D Milligan

×

44

Publications

3.6K

Citations

28

H-Index

YearCitations

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

David C. Linch, A. H. Goldstone, Annabel McMillan,

The Lancet

1993

1K

Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus

Peter Dreger, Paolo Corradini, Eva Kimby,

Leukemia

2006

381

Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen

J. M. Davies, Rosemary A. Barnes, D Milligan

Clinical Medicine

2002

284

Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis

Peter Dreger, R. Brand, D Milligan,

Leukemia

2005

159

The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison

Alan K. Burnett, Robert K. Hills, Ann E. Hunter,

Leukemia

2012

158

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Bronwen E. Shaw, G J Mufti, Stephen Mackinnon,

Bone Marrow Transplantation

2008

111

Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation

Alex Molassiotis, Olga van den Akker, D Milligan,

Journal of Psychosomatic Research

1997

103

Quality of life in long-term survivors of marrow transplantation: comparison with a matched group receiving maintenance chemotherapy.

Alex Molassiotis, Olga van den Akker, D Milligan,

PubMed

1996

99

High-dose therapy and autologous stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT

J. Sweetenham, G. Taghipour, D Milligan,

Bone Marrow Transplantation

1997

96

Allogeneic peripheral blood stem cell transplantation for haematological malignancies – an analysis of kinetics of engraftment and GVHD risk

Gail Miflin, NH Russell, R. M. Hutchinson,

Bone Marrow Transplantation

1997

92

Page 1